Corrigendum to: Nanoparticle-Mediated Transcytosis in Tumor Drug Delivery: Mechanisms, Categories, and Novel Applications

In the published article [1], text under heading 5 was inadvertently omitted during the final processing of the manuscript. This error has now been corrected, and the references have been updated. This correction does not affect the scientific content, data interpretation, or conclusions of the article. The original article is available online at: https://www.benthamscience.com/article/143767 The publisher apologizes for any inconvenience caused to the authors and readers. Details of the correction are provided below: Corrected: 5. THE DIFFERENCE BETWEEN AMT, RMT, AND CMT AMT, RMT, and CMT represent distinct transcytosis mechanisms: AMT relies on non-specific electrostatic interactions, RMT depends on specific binding to cellsurface receptors, while CMT utilizes carrier cells (e.g., immune cells) to transport drugs or nanoparticles. The key differences between these mechanisms are summarized in Table 2.